# Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

> **NCT07484243** · — · RECRUITING · sponsor: **Yuanyuan Zhang** · enrollment: 10000 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)
- Rheumatoid Arthritis-Associated Interstitial Lung Disease
- Difficult-to-Treat Rheumatoid Arthritis

## Interventions

- **DRUG:** Integrated Traditional Chinese and Western Medicine
- **OTHER:** Integrated Traditional Chinese and Western Medicine

## Key facts

- **NCT ID:** NCT07484243
- **Lead sponsor:** Yuanyuan Zhang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-22
- **Primary completion:** 2028-09-30
- **Final completion:** 2029-03-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07484243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07484243, "Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07484243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*